Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer

Clinical targeted sequencing allows for the selection of patients expected to have a better treatment response, and reveals mechanisms of resistance to molecular targeted therapies based on actionable gene mutations. We underwent comprehensive genomic testing with either our original in-house CLHURC...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagio, Kanako, Amano, Toraji, Hayashi, Hideyuki, Takeshita, Takashi, Oshino, Tomohiro, Kikuchi, Junko, Ohhara, Yoshihito, Yabe, Ichiro, Kinoshita, Ichiro, Nishihara, Hiroshi, Yamashita, Hiroko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047009/
https://www.ncbi.nlm.nih.gov/pubmed/33854152
http://dx.doi.org/10.1038/s41598-021-87645-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047009/
https://www.ncbi.nlm.nih.gov/pubmed/33854152
http://dx.doi.org/10.1038/s41598-021-87645-6

Ejemplares similares